Use of Next-Generation Sequencing in a State-Wide Strategy of HIV-1 Surveillance: Impact of the SARS-COV-2 Pandemic on HIV-1 Diagnosis and Transmission
https://t.co/nKJtal0wit
In the latest HIV and ID Observations, @PaulSaxMD looks at the legacy of the SWITCHMRK trial of raltegravir and discusses a case in which a doctor wonders whether an #HIV patient's treatment regimen can be simplified. Take the poll: https://t.co/5zcn8dqqsT #IDTwitter
Anthony Fauci only needed two graphs to explain the pathogenesis of HIV and the success of ART in the oval office. How many times have we used the lower graph?
https://t.co/N49mZ3VTKj
#covid19 🦠Nella popolazione di età 60-79 anni, per i non vaccinati il tasso di mortalità risulta quasi tre volte più alto vs ai vaccinati con booster e tre volte e mezzo rispetto ai vaccinati con quarta dose da meno di 120 giorni. Leggi il report esteso https://t.co/lD7rJTPG49
"Elimination of mother-to-child transmission of #HIV, #syphilis and viral #hepatitisB: A call for renewed global focus." Read more of this editorial in the International Journal of Infectious Diseases! #IJID#ISID#WorldAIDSDay2022
https://t.co/EkGo7THJSZ
Today, HHS announced it will adopt the @WHO’s new preferred term “mpox” instead of monkeypox disease and will use it from now on to avoid stigma around the disease and further promote access to quality care.
https://t.co/uRYvqW9NuH
CTS #AIFA approva dose booster con #vaccini bivalenti Comirnaty e Spikevax, fortemente raccomandata in via prioritaria ai soggetti che presentano fattori di rischio e agli over 60.
Leggi il comunicato👇
https://t.co/LQ6ILwhJbq
Just published @NEJM
A marked reduction of death (~80%) and hospitalization (~70%) for Paxlovid in people age 65+ during the Omicron wave in Israel, not seen in the 40-64 year age group
https://t.co/1fmfcbI6ux